Contact this trialFirst, we need to learn more about you.
Vasopressor
Angiotensin II for AKI after Liver Transplantation
Recruiting3 awardsPhase 4
Los Angeles, California
This trial will investigate whether the administration of angiotensin 2, a new vasopressor drug, during liver transplant surgery can decrease the rate of kidney injury after transplantation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.